Analyst Ratings for King Pharmaceuticals (KG) [Neutrals]
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/13/2010 | Wells Fargo | Downgrade | Market Perform (N/A) |
N/A (N/A) |
14.14 | 14.24 | 0.71% | Details |
| 10/13/2010 | UBS | Downgrade | Neutral (N/A) |
N/A (N/A) |
14.14 | 14.24 | 0.71% | Details |
| 10/12/2010 | Duncan Williams | Downgrade | Hold (N/A) |
N/A (N/A) |
14.14 | 14.24 | 0.71% | Details |
| 10/12/2010 | Collins Stewart | Downgrade | Neutral (N/A) |
N/A (N/A) |
10.15 | 14.24 | 40.3% | Details |
| 10/5/2010 | Susquehanna | New Coverage | Neutral (N/A) |
N/A (N/A) |
9.97 | 14.24 | 42.83% | Details |
| 8/10/2010 | Buckingham Research | Downgrade | Neutral (N/A) |
N/A (N/A) |
9.18 | 14.24 | 55.12% | Details |
| 7/19/2010 | Goldman Sachs | Upgrade | Neutral (N/A) |
N/A (N/A) |
8.37 | 14.24 | 70.13% | Details |
